TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

Trial Identifier: D5180C00034
Sponsor: AstraZeneca
Start Date: April 2023
Primary Completion Date: November 2029
Study Completion Date: November 2029

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aichi, Japan
Japan Akita, Japan
Japan Aomori, Japan
Japan Chiba, Japan
Japan Fukui, Japan
Japan Fukuoka, Japan
Japan Hiroshima, Japan
Japan Hokkaido, Japan
Japan Hyogo, Japan
Japan Ibaraki, Japan
Japan Ishikawa, Japan
Japan Iwate, Japan
Japan Kagawa, Japan
Japan Kanagawa, Japan
Japan Kumamoto, Japan
Japan Kyoto, Japan
Japan Miyagi, Japan
Japan Nara, Japan
Japan Oita, Japan
Japan Okayama, Japan
Japan Shimane, Japan
Japan Shizuoka, Japan
Japan Toyama, Japan
Japan Wakayama, Japan
Japan Yamagata, Japan
Japan Yamaguchi, Japan
Japan Yamanashi, Japan